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Abstract 
 
Vibrio vulnificus is a ubiquitous estuarine microorganism but causes fatal systemic 
infections in immunocompromised humans, cultured eels or shrimps. An extracellular 
metalloprotease VVP has been reported to be a potential virulence factor of the bacterium; 5 
however, a few strains isolated from a diseased eel or shrimp were recently found to 
produce a serine protease termed VvsA, but not VVP. In the present study, we found that 
these strains had lost the 80 kb genomic region including the gene encoding VVP. We also 
purified VvsA from the culture supernatant through ammonium sulfate fractionation, gel 
filtration and ion-exchange column chromatography, and the enzyme was demonstrated to 10 
be a chymotrypsin-like protease, as well as those from some vibrios. The gene vvsA was 
shown to constitute an operon with a downstream gene vvsB, and several Vibrio species 
were found to have orthologues of vvsAB. These findings indicate that the genes vvp/vvpE 
and vvsAB might be mobile genetic elements. 
 15 
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Introduction 
 
Vibrio vulnificus is a motile and facultative anaerobic gram-negative bacterium and 
inhabits ubiquitously at estuarine and marine environments (Janda et al., 1988; 
Chakraborty et al., 1997). However, after consumption of contaminated seafood, this 5 
species causes fatal septicemia in humans who have underlying diseases such as hepatic 
cirrhosis, hepatitis or diabetes (Strom and Paranjpye, 2000; Miyoshi 2006). Although V. 
vulnificus infections have been documented in many countries such as the United States, 
Japan and South Korea, no epidemic case is reported. In addition, this species causes 
epidemic and serious systemic infections called vibriosis in cultured eels (Tison et al., 10 
1982). Currently, the genomic nucleotide sequences of some human clinical isolates 
including strain YJ016 (accession numbers, BA000037 for chromosome I, and BA000038 
for chromosome II) are available on the database. 
An extracellular metalloprotease, VVP (V. vulnificus protease) or VvpE, is a potential 
virulence factor of the bacterium (Miyoshi and Shinoda, 1997). The purified enzyme has 15 
been reported to enhance vascular permeability due to exocytotic histamine release from 
mast cells and/or due to activation of the bradykinin-generating cascade, and to evoke the 
hemorrhagic skin damage through digestion of the vascular basement membrane. 
Additionally, VVP can disturb the host’s physiological homeostasis through disordered 
proteolysis of many kinds of plasma proteins, which may elicit eventually an 20 
immunocompromised state in the host. The experiments using the VVP/VvpE mutants or 
the protease inhibiters have also indicated significant roles of the metalloprotease in the 
bacterial pathogenicity (Miyoshi and Shinoda, 1988; Miyoshi et al., 1994; Valiente et al., 
2008). 
Wang et al. (2008) recently carried out the genotyping of V. vulnificus clinical strains 25 
 5 
based on the vvp/vvpE gene. Most strains were apparently classified into the genotype A or 
B by the PCR (polymerase chain reaction) method. However, a few strains from diseased 
eel or shrimp could not be categorized because no PCR product was obtained, which 
suggested the absence of the vvp/vvpE gene. Interestingly, theses strains were found to 
produce a serine protease (VVA0302 of strain YJ016) instead of VVP/VvpE (VVA1465 of 5 
strain YJ016) (Wang et al., 2008). Several Vibrio species including human or fish 
pathogens have been documented to secrete a serine protease (Shinoda and Miyoshi 2011). 
For instance, Vibrio parahaemolyticus, a causative agent of human wound infections or 
gastroenteritis, produces an extracellular serine protease termed VPP1 or protease A 
(Ishihara et al., 2002; Lee et al., 2002). This serine protease is also a putative virulence 10 
factor. Lee et al. (2002) reported that the purified enzyme had the cytotoxic activity to 
CHO, HeLa and Vero cells and the lethal activity to mice. 
In the present study, we first clarified whether the non-classified strains had lost only 
the vvp/vvpE gene or the larger genomic region including the metalloprotease gene. Next, 
we carried out purification and characterization of V. vulnificus serine protease that was 15 
designated as VvsA. In addition, we undertook the sequencing and analysis of the vvsA 
gene. 
 
 
Materials and methods 20 
 
Bacterial strains 
 
Five clinical strains were used for the present study. Among them, strain ATCC 33149 
(isolated in Japan), CECT 5343 (in Spain), E86 (in Spain) and NCIMB 2137 (in Japan) 25 
 6 
were from eels, whereas strain 520 (in Taiwan) was from a shrimp. The vvp/vvpE genotype 
of strain CECT 5343 and E86 are type A and type B respectively; however, remaining 
three strains (strain ATCC33149, NCIMB 2137 and 520) are vvp/vvpE negative (Wang et 
al., 2008). For VvsA purification, strain NCIMB 2137 was used because the culture 
supernatant from this strain showed the highest proteolytic activity (Wang et al., 2008). 5 
 
PCR amplification of upstream or downstream genes of vvp/vvpE 
 
The bacterium was cultivated at 37 oC in Luria-Bertani (LB) broth (1 % tryptone, 0.5 % 
yeast extract, 2.0 % NaCl, pH 7.5) with shaking, and the genomic DNA was extracted at 10 
the middle logarithmic growth phase as reported (Senoh et al., 2005). Appropriate PCR 
primers for amplification of the target genes were designed based on the nucleotide 
sequences of strain YJ016 (accession number, BA000038).  
The bacterial genomic DNA (100 ng in 1 µl), Go Taq Green Master Mix (Promega, 
Madison, WI, USA) (12.5 µl) and each of the primer set (20 pmol in 2 µl) were mixed, and 15 
the total volume of the mixture was adjusted to 25 µl with purified water. Thereafter, the 
reaction mixture prepared was heat-treated at 94 oC for 2 min, and PCR amplification was 
carried out for 25 cycles as following: 30-sec denaturation at 94 oC, 30-sec annealing at 58 
oC, and 90-sec extension at 72 oC. After PCR, the products were electrophoresed on a 
1.5 % agarose gel and visualized by staining with ethidium bromide. 20 
 
Purification of VvsA from strain NCIMB 2137 
 
Strain NCIMB 2137 was cultivated in TYE broth (0.5 % tryptone, 0.25 % yeast extract, 
2.0 % NaCl, 25 mM K2HPO4, pH 7.5) at 26 oC with shaking. At the early stationary 25 
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growth phase (at 20-hr cultivation), the culture supernatant was collected by centrifugation 
at 7,000 x g for 40 min, and ammonium sulfate was added to 70 % saturation (472 g/l). 
The resulting precipitate was collected, dissolved in a small volume of distilled water, and 
dialyzed against 50 mM Tris-HCl buffer (pH 7.5) containing 4 mM CaCl2 for 24 hr. The 
preparation thus obtained was applied to a HiLoad 26/60 Sephacryl S-300 HR column (GE 5 
Healthcare, Buckinghamshire, England) equilibrated with 50 mM Tris-HCl buffer (pH 7.5) 
containing 4 mM CaCl2 and 0.02 % NaN3 (buffer A). The fractions showed the high 
proteolytic activity toward azocasein (Sigma-Aldrich, St Louis, MO, USA) were collected 
and concentrated by ultra-filtration with a Dioaflo membrane YM30 (Millipore, Billerica, 
MA, USA). Then, the concentrated preparation was loaded on a Fractogel EMD TMAE 10 
650 5/5 column (Merk, Darmstadt, Germany) equilibrated with buffer A, and the linear 
gradient elution with 0-0.5 M NaCl in buffer A was carried out. The protein peak with the 
sufficient proteolytic activity was collected and used as the final VvsA preparation.  
 
Polyacrylamide gel electrophoresis (PAGE) and the N-terminal amino acid sequencing 15 
 
For SDS-PAGE, the sample was treated with 2 % SDS at 100 oC for 3 min and was 
subjected to gel electrophoresis on the PhastSystem using a PhastGel Gradient 10-15 
(GE-Healthcare). After electrophoresis, the gel was stained with 0.25 % Coomassie 
brilliant blue R-250 (CBB) and destained with 25 % ethanol-8 % acetic acid. Native PAGE 20 
on the PhastSystem was carried out with a PhastGel Gradient 8-25 (GE Healthcare). After 
native PAGE, one of the gels was stained with CBB in order to visualize the proteins, 
whereas another gel was embedded into 2 % skim milk agar (pH 7.5) and incubated at 30 
oC for 3 hr for detection of the proteolytic activity. 
For the N-terminal amino acid sequencing, the proteins separated by SDS-PAGE were 25 
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transferred to a PVDF membrane and stained with CBB. Thereafter, an appropriate protein 
band was cut off from the membrane, and its N-terminal amino acid sequence was 
determined by Edman degradation with an automatic protein sequencer Model 473A 
(Applied Biosystems, Foster City, CA, USA). 
 5 
Assay of the protease activity 
 
The proteinase activity was assayed with 1 % azocasein as described previously (Miyoshi 
et al. 1987) with some modifications. Briefly, the sample was allowed to act on azocasein 
(1 mg) in 0.3 ml of 50 mM Tris-HCl buffer (pH 8.0) at 30 oC for 15 min. Thereafter, the 10 
reaction was stopped by the addition of 0.7 ml of 5 % trichloroacetic acid, and the reaction 
mixture was centrifuged at 1,500 x g for 5 min. The supernatant was collected and mixed 
with an equal volume of 0.5 M NaOH, and then absorbance at 440 nm was measured. One 
proteinase unit (PU) was defined as the amount of the enzyme hydrolyzing 1 µg of 
azocasein in 1 min.  15 
The peptidase activity was assayed with peptidyl-4-methylylcoumaryl-7-amide 
(MCA) substrates developed for human serine proteases. The following substrates, 
t-butyloxycarbonyl (Boc)-Arg-Val-Arg-Arg-MCA (for furin), Boc-Glu-Lys-Lys-MCA (for 
plasmin), Boc-Gln-Ala-Arg-MCA (for trypsin), succinyl (Suc)-Ala-Ala-Pro-Phe-MCA (for 
chymotrypsin), and Boc-Gln-Gly-Arg-MCA (for factor XIIa) were used. These substrates 20 
were purchased from Peptide Institute (Minoh, Japan) and dissolved in dimethyl sulfoxide 
at a concentration of 150 mM. For the assay, the sample was allowed to act on the 
substrate (300 nmol) in 0.3 ml of 50 mM Tris-HCl buffer (pH 8.0) at 30 oC for 30 min. 
Thereafter, the reaction was terminated by the addition of 0.7 ml of ice-cold citrate buffer 
(pH 5.0), and the liberation of 7-amino-4-metylcoumarine from the substrate was 25 
 9 
determined by measuring absorbance at 370 nm. 
 
Amplification and sequencing of the vvsA-vvsB genes of strain NCIMB2137 
 
In chromosome II of V. vulnificus strain YJ016 (accession number, BA000038), VVA0302 5 
(2025 bp; vvsA of strain NCIMB 2137) is separated to VVA0301 (348 bp; vvsB of strain 
NCIMB 2137) by only 6 bp, suggesting two genes constitute an operon. For PCR 
amplification of the full-length vvsA-vvsB genes, appropriate PCR primers were designed 
from the nucleotide sequences of VVA0303 and VVA0300. The primers were mixed with 
the genomic DNA from strain NCIMB 2137 and TaKaRa Ex TaqTM polymerase 10 
(Takara-Bio, Otsu, Japan). The reaction mixture thus prepared was heat-treated at 95 oC for 
2 min and subjected to the amplification reactions (25 cycles) with the following 
conditions, 10-sec denaturation at 98 oC, 30-sec annealing at 58 oC and 5-min extension at 
72 oC.  
After PCR, the nucleotide sequence of the amplicon was determined by using a 15 
BigDyeTM Terminator Cycle Sequence Kit (Applied Biosystems, Foster City, CA, USA) 
and ABI PRISMTM 3100 Genetic Analyzer (Applied Biosystems). The nucleotide sequence 
data of the vvsA-vvsB genes of strain NCIMB 2137 was deposited in the 
DDBJ/EMBL/GenBank database under the accession number AB509375. 
 20 
Reverse transcription PCR (RT-PCR) 
 
Total RNA was extracted from strain NCIMB 2137 at the early stationary growth phase 
and treated with DNase I (Invitrogen, Carlsbad, CA, USA) as reported (Kawase et al., 
2004). Thereafter, an aliquot (200 ng) was added to the Ready-To-Go RT-PCR Kit (GE 25 
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Healthcare) and incubated at 42 oC for 30 min for RT reaction. Then, the reverse 
transcriptase was inactivated by heat-treatment at 95 oC for 5 min. The PCR amplification 
using appropriate primers corresponding to the outside or inside of vvsA-vvsB (Fig. 1) was 
performed for 30 cycles as follows: 30-sec denaturation at 95 oC, 30-sec annealing at 58 oC 
and 2-min extension at 72 oC. After PCR, the products were electrophoresed on a 1.5 % 5 
agarose gel and visualized by staining with ethidium bromide. 
 
 
Results and discussion 
   10 
Deletion of the 80 kb genomic region in the vvp/vvpE negative strains 
 
Comparative genomic studies have revealed that the genes around vvp/vvpE are commonly 
conserved in V. vulnificus strains from clinical and environmental sources (Quirke et al., 
2006; Gulig et al., 2010). In order to clarify whether the vvp/vvpE negative strains have lost 15 
only the metalloprotease gene or the much larger genomic region, a series of PCR 
experiments targeting upstream genes of vvp/vvpE (VVA1465) were carried out (Table 1). 
Up to VVA1436, the amplicons with suitable sizes were produced from all strains tested. 
However, in the experiment targeting the VVA1437 gene, no DNA fragment was amplified 
from the vvp/vvpE negative strains (strain ATCC33149, NCIMB2137 and 520). On the 20 
other hand, when downstream genes were targeted, amplicons of VVA1527 or VVA1526 
were ordinarily obtained in all strains; however, the fragment of VVA1524 was not 
amplified in the vvp/vvpE negative strains (Table 1). The PCR targeting VVA1525 (156 bp) 
was not carried out because the suitable primers could not be designed.  
In the vvp/vvpE negative strains, about 3 kb fragment was commonly produced when 25 
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the PCR amplification between VVA1436 and VVA1526 was carried out (data not shown). 
The sequencing of the 3 kb fragment from strain ATCC33149 was performed and the 
results revealed that the full-size VVA0256 gene (1338 bp), but not VVA1525, was 
contained in the fragment. This indicates that VVA0256 has moved and inserted into 
downstream of VVA1436. Although no experimental evidence has been documented, the 5 
product of VVA0256 is a putative transposase or its inactivated derivative (accession 
number, BA000038). Therefore, this protein might be related to deletion of the genomic 
elements involving vvp/vvpE. 
Taken together, as shown in Fig. 2, it may be concluded that the vvp/vvpE (VVA1465) 
negative strains has lost the 80 kb genomic region corresponding to the genes from 10 
VVA1437 to VVA1525 (accession number, BA000038). It should be noted that the G+C 
nucleotide content of the 80 kb region is 49 %, whereas that of chromosome II is 47 % 
(Chen et al., 2003). This supports the idea that the 80 kb genomic region might be 
transferred from another bacterial species. However, in order to verify the idea, the more 
detailed analysis of G+C variation over different scales is required. Some Vibrio species 15 
are known to possess orthologues of vvp/vvpE (Miyoshi and Shinoda, 1997; Shinoda and 
Miyoshi, 2011). The comparative analysis of the genes around the orthologues would be 
useful to clarify whether the 80 kb region is a movable element or not. 
 
Purification and characterization of VvsA produced by strain NCIMB 2137 20 
 
Wang et al. (2008) reported that LB broth might be not suitable for purification of VvsA, 
because the protease secreted was found to associate with some proteins contained in the 
broth. Therefore, we used TYE broth in the present study. As reported by Wang et al. 
(2008), the culture supernatant was collected at the early stationary growth phase and 25 
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fractionated by ammonium sulfate precipitation, gel filtration and ion-exchange column 
chromatography. However, VvsA showed the apparently different elution profile. Namely, 
in the final ion-exchange column chromatography, the main protease peak was around 0.2 
M NaCl when cultivated in TYE broth (Fig. 3A). In contrast, when cultivated in LB broth, 
the protease was eluted around 0.3 M NaCl (Wang et al., 2008). 5 
The major protease eluted around 0.2 M NaCl was collected and subjected to 
SDS-PAGE. As shown in Fig. 3B, a single 45 kDa protein was visualized. The native 
PAGE analysis showed that the 45 kDa protein had the significant proteolytic activity 
toward skim milk (data not shown). Additionally, the N-terminal amino acid sequence of 
the 45 kDa protease was found to be NH2-SETTPWGYGA, which correspond surely with 10 
Ser122 to Ala131 of VVA0302 (VvsA). Therefore, the final preparation was used as purified 
VvsA in the next experiments. The typical purification result is summarized in Table 2. 
The purified protease showed the 1,770-fold specific activity than that of the culture 
supernatant. However, as small amounts as 80 µg was obtained from 2,400 ml of the 
culture supernatant. 15 
As reported by Wang et al. (2008), the second peak around 0.3 M NaCl contained the 
59 kDa protein, and its N-terminal amino acid sequence was identical with that of 45 kDa 
VvsA (data not shown). This demonstrates that 45 kDa mature VvsA was derived from the 
59 kDa intermediate through removal of the C-terminal 14 kDa polypeptide. The 
extracellular processing of proteolytic enzymes is not unique in Vibrio species. For 20 
instance, the C-terminal 10 kDa polypeptide of VVP/VvpE is also digested after secretion 
into the cultivation broth (Miyoshi and Shinoda, 1997). 
In order to determine the optimum pH, VvsA (1.0 µg) was allowed to act on azocasein 
in 60 mM GTA (3,3-dimethylglutaric acid, Tris, 2-amino-2-methyl-1,3-propandiol) buffer 
(pH 6.0-10.0). Although the protease showed the significant activity at broad pH range, the 25 
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maximal activity was observed at pH 9.0. Next, VvsA (1.0 µg) was allowed to act on 
azocasein at 20-70 oC to test the optimum temperature. Up to 50 oC, the proteolytic activity 
was increased depending on the incubation temperature; however, the activity was rapidly 
decreased at higher than 50 oC. 
When purified VvsA was allowed to act on several peptidyl-MCA substrates, only 5 
one substrate Suc-Ala-Ala-Pro-Phe-MCA (for chymotrypsin) was steadily hydrolyzed 
(data not shown). Chymostatin is a well-known competitive inhibitor for both 
chymotrypsin and chymotrypsin-like bacterial serine protease (Ishihara et al., 2002). To 
examine the inhibitory potential of chymostatin, VvsA (0.64 µg) was treated with various 
amounts of the inhibitor at 30 oC for 10 min, and the residual proteolytic activity was 10 
measured with azocasein. Chymostatin could inactivate VvsA in a dose-dependent manner, 
and 50 % of the activity was abolished by the treatment with 0.12 µg of the inhibitor (data 
not shown). Taken together, it may be concluded that, likewise VPP1/protese A from V. 
parahaemolyticus (Ishihara et al., 2002), VvsA is a chymotrypsin-like alkaline serine 
protease. 15 
 
Genetic analysis of vvsA of strain NCIMB 2137 
 
About 3.3 kb DNA fragment of strain NCIMB 2137 containing the full length of the 
vvsA-vvsB genes was amplified by PCR, and its nucleotide sequence was determined 20 
(accession number, AB509375). It was revealed that both vvhA (2025 bp) and vvhB (348 
bp) of strain NCIMB 2137 were almost identical to the genes of strain YJ016 (VVA0302 
and VVA0301). Namely, the identity between vvhA and VVA0302, and between vvhB and 
VVA0301 was 97.2 % (1963/2025) and 98.0 % (341/348), respectively (data not shown). 
additionally, as well as VVA0302 and VVA0301, vvsA and vvsB were separated by only 6 25 
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bp. 
The identity of the deduced amino acid sequences is shown in Table 3 and 4. The 
identity of the VvsA precursor (674 aa) to VVA0302 is 98.8 % (666/674), whereas in the 
case of the VvsB precursor (115 aa), the identity is as high as 99.1 % (114/115). The 
homologues of VvsA and VvsB precursors were found in several Vibrio species (Table 3 5 
and 4), suggesting widely distribution of the serine protease family in vibrios. The identity 
was 71.7 % to 77.2 % among the homologues of VvsA precursor; however, the identity 
was apparently low (36.5 % to 56.5 %) in the case of the VvsB homologues.  
VvsA was also similar to an extracellular serine protease, Apa1, produced by 
Pseudoalteromonas sp. strain AS-11. Namely, the identity of the precursors and the mature 10 
enzymes were 57.9 % and 68.0 %, respectively. Based on the crystal structure of Apa1 
(Dong et al., 2005), the tertiary structure model of VvsA was constructed by using the 
SWISS-MODEL Workspace (Arnold et al., 2006). The model revealed that three crucial 
amino acid residues (Asp151, His186 and Ser490) mediating the catalytic reaction were 
located in the cleft of the active center of the enzyme (data not shown). 15 
In order to clarify that the vvsA gene constitutes an operon with the downstream gene 
vvsB, we carried out RT-PCR experiments using several sets of the primers, of which 
locations are the inside or outside of vvsA-vvsB (Fig. 1). The results showed that, at least in 
strain NCIMB 2137, the vvsA and vvsB genes are a single transcriptional unit (Table 5).  
V. vulnificus is known to produce an extracellular hemolytic toxin VVH (V. vulnificus 20 
hemolysin). The vvhA gene (1416 bp) encoding the toxin is transcribed together with 
another gene vvhB (507 bp), which are separated by only 1 bp. The recent study apparently 
indicated that the product of vvhB functioned as a chaperone supporting the maturation 
process of VVH (Senoh et al., 2008). Therefore, the product of vvsB may be also a 
chaperone essential for maturation of VvsA. 25 
 15 
 
In conclusions, the present study demonstrated that the vvp/vvpE negative strains had 
lost the large genomic region and that orthologues of vvsA were present in several Vibrio 
species, which suggest that both vvp/vvpE and vvsA are movable genetic elements. 
 5 
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Table 1 PCR amplification of the genes locating the downstream or upstream of vvp/vvpE 
Strain 
Genea 
CECT5343 E86 ATCC33149 NCIMB 2137 520 
VVA1435 + + + + + 
VVA1436 + + + + + 
VVA1437 + + -b - - 
VVA1465 
(vvp/vvpE) 
+     
(Type A) 
+   
(Type B) 
- - - 
VVA1524 + + - - - 
VVA1526 + + + + + 
VVA1527 + + + + + 
a The VVA1525 gene was not tested because the suitable primers could not be designed 
b No amplicon was obtained 
 19 
 
Table 2 Purification of VvsA 
Purification step 
Total 
protein 
(mg) 
Total 
activity 
(PU) 
Specific 
activity 
(PU/mg) 
Relative 
activity 
Yield of 
activity 
(%) 
Culture supernatant 2,400.00 34,800 15 1.0 100.0 
Ammonium sulfate 
fractionation 
28.00 24,670 880 60.0 71.0 
Gel filtration 2.40 8,400 3,500 230.0 24.1 
Ion-exchange column 
chromatography 
0.08 2,130 26,600 1,770.0 6.1 
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Table 3 Identity of amino acid sequences of the proteins homologous to the VvsA 
precursor of V. vulnificus strain NCIMB 2137 
Strain Protein Identity (%) 
V. vulnificus YJ016 VVA0302 (674 aa) 98.8 
V. alginolyticus 12G01 EAS77411 (676 aa) 77.2 
V. parahaemolyticus RIMD 2210633 VPA0227 (677 aa) 76.9 
Vibrio sp. Ex25 VEA 000775 (677 aa) 76.9 
V. orientalis CIP 102891 EEX93955 (673 aa) 72.7 
V. brasiliensis LMG 20546 EGAG3986 (676 aa) 71.7 
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Table 4 Identity of amino acid sequences of the proteins homologous to the VvsB 
precursor of V. vulnificus strain NCIMB 2137 
Strain Protein Identity (%) 
V. vulnificus YJ016 VVA0301 (115 aa) 99.1 
V. alginolyticus 12G01 EAS77410 (120 aa) 51.3 
V. parahaemolyticus RIMD 2210633 VPA0228 (115 aa) 56.5 
Vibrio sp. Ex25 VEA 000774 (116 aa) 52.2 
V. orientalis CIP 102891 EEX93956 (115 aa) 44.3 
V. brasiliensis LMG 20546 EGAG3985 (110 aa) 36.5 
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Table 5 RT-PCR to detect vvsAB mRNA 
Reverse transcriptase Sense	  
primer 
Antisense 
primer Active Inactivea 
F1 R3 - - 
F2 R3 + - 
F3 R2 + - 
F4 R1 - - 
a Reverse transcriptase was inactivated by heat treatment, and 
the PCR amplification was carried out without the RT 
reaction 
5 
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Figure legends 
 
Fig. 1. Locations and nucleotide sequences of primers used in the present study. 
 
Fig. 2. The genes present in the vvp/vvpE positive or negative strains. The broken gray line 5 
indicates the absence of the genes. 
 
Fig. 3. (A) The elution profile of the ion-exchange column chromatography. The 
preparation from gel filtration was loaded on a Fractogel EMD TMAE 650 5/5 column, 
and the linear gradient elution with 0-0.5 M NaCl was carried out at a flow rate of 0.5 10 
ml/min. The protein peak showed the sufficient proteolytic activity was collected. (B) The 
protein profiles of SDS-PAGE. The final preparation from ion-exchange column 
chromatography (3.4 µg) was treated with 2 % SDS at 100 oC for 3 min and subjected to 
gel electrophoresis on the PhastSystem using a PhastGel Gradient 10-15. After 
electrophoresis, the gel was stained with 0.25 % Coomassie brilliant blue R-250. Lane M, 15 
molecular weight marker proteins (97, 66, 45, 30, 20.1 and 14.1 kDa); and lane S, the final 
preparation. 
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Fig. 1 
(Miyoshi et al.) 
 
 
5 
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Fig. 2 
(Miyoshi et al.) 
 
 26 
Fig. 3 
(Miyoshi et al.) 
 
